Cannabis Industry News & Updates
102 articles covering regulatory changes, licensing updates, and industry news across 21 US states. Original analysis from government and industry sources.
March 2026
31
Mar
New York Officials Report $2.5 Billion in Cannabis Sales Since Legalization
New York officials reported that retail cannabis sales have surpassed $2.5 billion since adult-use legalization, with $1.6 billion generated in 2025 alone. Licensed storefronts nearly doubled from 261 in 2024 to 556 in 2025.
30
Mar
Congressman Presses DOJ and DEA on Cannabis Rescheduling Timeline
Congressman Steve Cohen sent a letter to AG Bondi and DEA Administrator Cole demanding an update on cannabis rescheduling progress. The letter came 99 days after Trump signed the executive order directing 'expeditious' completion of Schedule III rulemaking.
28
Mar
Maryland Lawmakers Pass Bill Protecting Firefighters Who Use Medical Cannabis Off Duty
Maryland's House of Delegates passed HB 797 by a 100-31 vote, protecting firefighters and rescue workers from employment discrimination for off-duty medical cannabis use. Registered patients cannot be punished for testing positive for cannabis metabolites.
18
Mar
New Congressional Research Report on Cannabis Rescheduling Published
Congressional researchers released a new analysis noting that rescheduling would be a 'transitional' step requiring follow-up banking, commerce, and justice reforms. The report emphasized that rescheduling alone would not bring state markets into compliance with federal law.
16
Mar
Virginia Legislature Sends Cannabis Sales Legalization Bill to Governor
Virginia's legislature voted to adopt legislation legalizing adult-use cannabis dispensary sales, sending the bill to Gov. Spanberger's desk. The bill sets a January 1, 2027 launch date for retail sales, covering taxes, licensing, and regulatory duties.
12
Mar
Cannabis MSOs Owe $1.6 Billion in Unpaid 280E Taxes as IRS Fights Back
Major cannabis multistate operators collectively owe more than $1.6 billion in unpaid federal taxes under Section 280E. The IRS argued that Trump's rescheduling executive order does not change tax obligations because it has not been finalized.
12
Mar
IRS Disputes Cannabis Company's Challenge to 280E in Tax Court
The IRS filed arguments in Tax Court against New Mexico cannabis company Ultra Health, which challenged the applicability of Section 280E. The IRS called Ultra Health's argument for the court to conduct its own rescheduling review an 'imaginary process.'
10
Mar
Michigan Cannabis Sales Fall to Lowest Level in Two Years Under New Wholesale Tax
Monthly cannabis sales in Michigan fell to their lowest level in more than two years as the new 24% wholesale tax continued to squeeze the market. Eight state senators announced plans to repeal the tax, arguing it is devastating the industry.
6
Mar
Federal Government Warns About Cannabis and Hemp in Drug Tests
Federal agencies issued warnings about the impact of medical cannabis and hemp product use on standard drug testing protocols. The guidance came amid growing tension between state-legal marijuana programs and federal workplace testing requirements.
5
Mar
Texas Voters Overwhelmingly Approve Cannabis Legalization Ballot Measure
Texas voters in the Democratic primary approved a nonbinding marijuana legalization ballot question by a margin of 80% to 20%. The measure asked whether the state should legalize cannabis for adults and automatically expunge records for past offenses.
5
Mar
House Agriculture Committee Advances Farm Bill Without Hemp THC Ban Delay
The House Committee on Agriculture voted 34-17 to approve the Farm, Food, and National Security Act of 2026 without provisions to delay the hemp THC ban. The bill tightens the definition of hemp to include a 0.3% total THC pre-harvest test.
3
Mar
Supreme Court Justices Skeptical of Trump DOJ's Defense of Cannabis Gun Ban
During oral arguments in U.S. v. Hemani, most Supreme Court justices appeared skeptical of the Trump administration's defense of the federal firearms ban for marijuana users. Several justices suggested the pending rescheduling action undermines the government's case.
2
Mar
New York Cannabis Products Recalled Over Unreliable Lab Testing Results
New York's OCM issued its first product recall of 2026 after inspections revealed Keystone State Testing issued inaccurate safety certificates. A records audit found 54 product lots falsely reported as passing Aspergillus mold tests, affecting products from nearly two dozen companies.
February 2026
27
Feb
Hemp THC Ban Delay Hits Roadblock in Congress
The effort to delay the federal hemp THC product ban hit a major setback after two GOP-led amendments were not approved. The House Agriculture Committee chairman determined the delay amendments were not germane to the underlying Farm Bill.
26
Feb
ACLU Previews Cannabis and Guns Arguments Ahead of Supreme Court Hearing
The ACLU previewed its arguments for the Supreme Court hearing in U.S. v. Hemani, where the NRA joined marijuana advocacy groups urging justices to overturn the federal ban on gun ownership by cannabis consumers.
25
Feb
Congress Considers Hemp THC Product Ban Delay
Congressional lawmakers were set to consider a proposal to delay the federal ban on intoxicating hemp-derived THC products scheduled for November 13, 2026. The ban would outlaw hemp products with more than 0.4mg THC or synthetic cannabinoids like delta-8.
20
Feb
Cannabis Legalization Appears on Texas Democratic Primary Ballot
Texas Democrats placed a marijuana legalization question on the party's primary ballot asking voters whether the state should legalize cannabis for adults and automatically expunge records. Texas currently only operates a restrictive medical program with THC capped at 1%.
19
Feb
DOJ Tells Supreme Court Gun Ban for Marijuana Users Must Be Upheld
The DOJ argued before the Supreme Court that the federal gun ban for marijuana users must be upheld regardless of whether Trump's rescheduling order is finalized. This came despite an internal DOJ memo acknowledging that the ban is vulnerable to litigation.
15
Feb
Oklahoma House Passes License Moratorium Extension Through 2028
The Oklahoma House passed legislation to extend a moratorium on issuing new medical cannabis licenses through August 1, 2028. The bill also limits cultivation licenses to 2,500, reflecting concerns about market oversaturation.
12
Feb
New York Governor Forces Two Top Cannabis Regulators to Resign
Governor Hochul called for the resignations of the OCM's acting executive director and deputy counsel. John Kagia was appointed as the new acting executive director, with the appointment pending Senate confirmation.
9
Feb
FDA Faces Deadline for Cannabis Guidance on Hemp THC Serving Sizes
The FDA faced a deadline to publish cannabinoid lists and issue guidance on 'container' definitions for hemp product THC serving sizes. This stemmed from the hemp recriminalization legislation that imposed a 0.4 milligram THC limit per container.
6
Feb
Congressional Research Service Questions Constitutionality of Cannabis Tax Section 280E
A Congressional Research Service report found that whether Section 280E violates the Eighth Amendment's Excessive Fines Clause 'is a matter of debate.' While the Tax Court ruled in 2019 that 280E does not violate the clause, three dissenting judges concluded it imposes a fine.
January 2026
27
Jan
Cannabis M&A Activity Surges Following Trump Rescheduling Order
A flurry of cannabis mergers and acquisitions followed Trump's marijuana rescheduling executive order, driven by price compression and oversupply. Industry analysts cautioned that most deals have been tuck-in acquisitions rather than transformative consolidation.
26
Jan
Virginia Cannabis Sales Legalization Bills Advance in Legislature
Virginia's House and Senate advanced competing bills to legalize adult-use cannabis retail sales under the state's new Democratic trifecta. Cannabis has been legal to possess and home-grow in Virginia since 2021, but no retail marketplace existed until these bills began moving.
22
Jan
Tennessee Lawmakers Introduce Bipartisan Medical Cannabis Bill
Tennessee Representatives and Senators introduced bipartisan legislation to decriminalize possessing medical cannabis for patients with a physician's recommendation. Tennessee remains one of eight states without any medical cannabis program.
20
Jan
Big Banks Still Refusing Cannabis Industry Despite Trump Rescheduling Order
Major U.S. banks continued refusing to service the $32 billion legal cannabis industry despite Trump's rescheduling executive order. JP Morgan Chase indicated it was 'still too early to reconsider' without formal reclassification finalized.
19
Jan
Bipartisan Senators File Bill to Delay Federal Hemp THC Ban
Senators Klobuchar, Paul, and Merkley introduced a bill to delay enforcement of a law recriminalizing hemp THC products for two years. The delay was requested to give lawmakers time to develop regulatory alternatives to the outright prohibition.
15
Jan
Ohio Dispensaries Surpass $1 Billion in Legal Cannabis Sales in 2025
The Ohio Division of Cannabis Control reported that dispensaries sold more than $1 billion worth of combined recreational and medical marijuana products in 2025. This milestone came during the first full year of adult-use legalization, with sales having launched in August 2024.
13
Jan
Vireo Growth Acquires Eaze for $47 Million
Cannabis MSO Vireo Growth agreed to acquire Eaze, once known as the 'Uber of Weed,' in a $47 million all-stock deal. The acquisition gives Vireo an additional 65 retail locations and a delivery platform that has completed more than 12 million orders.
10
Jan
U.S. Active Cannabis Business Licenses Decline 13% Over Two Years
The number of active cannabis business licenses in the U.S. declined to 37,555, down about 1% from the prior quarter and extending a downturn since late 2022. Over the past two years, total active licenses fell 13%, reflecting industry consolidation.
9
Jan
Federal Medical Cannabis Protections Approved in Congress
The Senate voted to send President Trump a bill continuing protections for state medical cannabis programs from federal interference. The legislation did not include a rider that would have blocked the administration from completing the marijuana rescheduling process.
8
Jan
Trump Drug Czar Pushed to Back Full Cannabis Legalization
Advocates pushed President Trump's drug czar to support full cannabis legalization beyond Schedule III reclassification. The push came amid growing industry sentiment that rescheduling alone would not resolve the patchwork of state-federal conflicts facing the cannabis industry.
6
Jan
DEA Says Cannabis Rescheduling Process Remains Pending Despite Trump Executive Order
The DEA confirmed that the marijuana rescheduling appeal process remains pending despite President Trump's December 2025 executive order directing expedited movement from Schedule I to Schedule III. The process had been sidelined since January 2025, complicated by the DEA administrative law judge retiring.
5
Jan
Supreme Court Schedules Oral Arguments in Cannabis and Gun Rights Case
The U.S. Supreme Court scheduled oral arguments in U.S. v. Hemani, a case challenging the federal law banning marijuana users from possessing firearms. Several years of conflicting lower court rulings prompted the justices to decide whether Section 922(g)(3) is consistent with the Second Amendment.
5
Jan
Cannabis Edibles Giant Wyld Acquires Competitor Gron
Portland-based Wyld, the most recognized cannabis edibles brand in North America, announced the acquisition of fellow Oregon company Gron. The deal combines two leaders in the $4.8 billion edibles category, with Wyld operating in 16 states and roughly 7,500 retail locations.
5
Jan
Congress Removes Language Blocking Cannabis Rescheduling From Spending Bill
The House and Senate Appropriations committees released a bipartisan funding package that removed language intended to block the DOJ from rescheduling marijuana. This marked a significant retreat from earlier congressional efforts to strip the executive branch's authority over rescheduling.
1
Jan
Michigan's 24% Cannabis Wholesale Tax Takes Effect Despite Industry Lawsuit
Michigan's new 24% wholesale cannabis tax took effect January 1 after a judge denied the cannabis industry's request for an injunction. The tax is projected to generate roughly $420 million annually for road and bridge infrastructure.
December 2025
30
Dec
Missouri Cannabis Sales Hit Record $1.5 Billion
Missouri cannabis retailers reported a record $1.5 billion in sales for 2025, a 4% increase. The market generated a record $255 million in tax revenue, cementing Missouri as one of the fastest-growing markets.
20
Dec
Ohio Cannabis Sales Top $1 Billion in First Full Year
Ohio's cannabis market surpassed $1 billion in its first full year of recreational retail, with adult-use accounting for over $836 million. More than 130 cities enacted moratoriums banning recreational sales.
18
Dec
Trump Signs Executive Order to Reclassify Cannabis to Schedule III
President Trump signed an executive order directing Attorney General Bondi to expeditiously finalize moving cannabis from Schedule I to Schedule III. The order also included a Medicare provision covering up to $500 annually for CBD products starting April 2026.
15
Dec
Colorado Cannabis Sales Fall for Fourth Straight Year
Colorado cannabis sales fell for the fourth consecutive year to roughly $1.4 billion, the lowest since 2016. Active recreational cultivation licenses declined 48% between 2021 and 2025.
15
Dec
New York Legal Cannabis Sales Hit $1.5 Billion as Licensed Stores Double
New York's legal cannabis market saw explosive growth with sales topping $1.5 billion as licensed retailers more than doubled. NYC shut down 640 illicit shops since May, boosting legal market sales.
10
Dec
Oregon Cannabis Prices Hit Record Low After Largest-Ever Harvest
Oregon growers harvested over 13 million pounds in 2025, the largest crop on record, pushing median price per gram to $3.33. Annual sales fell from $960 million to $925.5 million despite steady demand.
1
Dec
Michigan Cannabis Revenue Drops Despite Record Unit Sales
Michigan retailers sold more cannabis products than ever, but plummeting prices drove revenue down $113 million to $3.17 billion. Rising volume with falling revenue illustrated the broader industry challenge.
November 2025
15
Nov
California Cannabis Sales Dip Below $4 Billion
California cannabis retailers reported $3.9 billion in sales for 2025, down from $4.2 billion, marking the third straight year of decline. The illicit market remained a dominant force, with the state reporting record seizures.
12
Nov
Trump Signs Federal Ban on Intoxicating Hemp Products
President Trump signed a bill banning most intoxicating hemp-derived products, recriminalizing the $28 billion hemp THC market. The ban limits products to 0.4 milligrams total THC per container and takes effect November 13, 2026.
September 2025
22
Sep
California Governor Signs Excise Tax Rollback to 15%
Governor Newsom signed legislation rolling California's cannabis excise tax back from 19% to 15%. The bill also froze the rate through June 2028, providing operators predictability after years of shifting tax burdens.
16
Sep
Minnesota Launches Recreational Cannabis Sales
Minnesota became the 23rd state with legal adult-use retail when non-tribal dispensaries began sales, two years after legalization. Vireo Growth led the launch with eight locations.
August 2025
15
Aug
Nevada Cannabis Sales Drop 8.6% Amid Tourism Slump
Annual Nevada cannabis sales dropped to $758 million, down 8.6%, mirroring a decline in Las Vegas tourism. Regulators signaled openness to easing restrictions on hotel delivery and consumption.
1
Aug
DEA Judge Retires, Leaving Cannabis Rescheduling in Limbo
DEA Administrative Law Judge Mulrooney retired, leaving the agency with no judges to oversee the rescheduling hearing. His departure shifted all pending matters to the newly confirmed DEA Administrator.
July 2025
22
Jul
Senate Confirms Terrance Cole as DEA Administrator
The Senate confirmed Terrance Cole as DEA Administrator by a 50-47 vote. Cole refused to commit to completing the Schedule III rulemaking and later omitted rescheduling from his strategic priorities.
1
Jul
Massachusetts Cannabis Lab Shuttered Over Fraud Allegations
Massachusetts suspended Assured Testing Laboratories, which handled roughly 25% of the state's testing, after finding its yeast and mold fail rate was 90 times lower than average. Investigators alleged the lab engaged in dry-labbing.
January 2025
17
Jan
Leafly Delisted from Nasdaq Stock Exchange
Cannabis platform Leafly was delisted from Nasdaq after failing to meet minimum income requirements. The company transitioned to over-the-counter trading, marking another casualty in the broader cannabis stock downturn.
16
Jan
Cannabis Lobbying Groups Merge to Form US Cannabis Roundtable
The National Cannabis Roundtable and U.S. Cannabis Council merged, unifying federal lobbying efforts. The combined organization represents operators across 38 states and nearly 450,000 employees.
15
Jan
Biden Commutes Nearly 2,500 Nonviolent Drug Sentences
In one of his final acts, President Biden granted clemency to nearly 2,500 people imprisoned for nonviolent drug convictions. Advocates welcomed the action but criticized the administration for leaving an estimated 1,500 people still incarcerated over federal cannabis offenses.
14
Jan
DEA Rescheduling Hearing Cancelled After Interlocutory Appeal
DEA Administrative Law Judge Mulrooney granted an interlocutory appeal that cancelled the scheduled cannabis rescheduling hearing, sidelining the entire process. The hearing was supposed to be a public debate on moving cannabis to Schedule III.
December 2024
30
Dec
U.S. Regulated Cannabis Sales Top $31.4 Billion in 2024
Total U.S. legal cannabis sales reached $31.4 billion in 2024, a 9.14% year-over-year increase. Price compression remained a major challenge, with prices per eighth dropping nearly 40% across many markets.
15
Dec
Michigan Surpasses $10 Billion in Cumulative Adult-Use Cannabis Sales
Michigan crossed the $10 billion cumulative adult-use sales milestone, becoming only the fourth state to reach that threshold. Annual 2024 sales hit $3.27 billion, a 9.9% increase over 2023.
15
Dec
SAFER Banking Act Fails to Advance in Lame-Duck Congress
The SAFER Banking Act failed to reach the Senate floor during the lame-duck session despite years of bipartisan support. The bill had cleared committee with a 14-9 vote but could not overcome scheduling and political obstacles.
2
Dec
Historic DEA Rescheduling Hearing Opens in Arlington, Virginia
The first DEA administrative hearing on marijuana rescheduling convened as a largely procedural session. Substantive testimony was scheduled to begin January 21, 2025.
November 2024
5
Nov
Florida Voters Reject Cannabis Amendment Despite 56% Majority Support
Florida's Amendment 3 received 56% support but failed to reach the 60% supermajority required. Trulieve spent over $60 million on the campaign, which earned Trump's endorsement but faced fierce DeSantis opposition.
5
Nov
Nebraska Voters Approve Medical Cannabis Legalization
Nebraska voters approved two complementary medical cannabis ballot initiatives with 71% and 67% support. However, results faced immediate legal challenges contesting the signature collection methods.
September 2024
20
Sep
Farm Bill Gets One-Year Extension, Leaving Hemp THC Loophole Intact
Congress extended the 2018 Farm Bill for another year rather than passing full reauthorization, leaving the hemp-derived THC loophole unchanged. Despite proposals to ban intoxicating hemp products, no changes were made.
6
Sep
DEA Schedules Administrative Hearing, Delays Final Rule Past Election
The DEA announced an administrative hearing on rescheduling, adding an extra step that pushed any final rule past the November election. The decision disappointed industry advocates who hoped for quicker resolution.
August 2024
15
Aug
Colorado Cracks Down on Cannabis Testing Fraud
Colorado officials uncovered two dozen cases of companies violating testing rules, including submitting different samples than what was sold. Regulators began weighing changes to sampling procedures to combat widespread fraud.
6
Aug
Ohio Launches Adult-Use Cannabis Sales With 98 Dispensaries
Ohio became the 24th state to open adult-use cannabis sales, with 98 dispensaries approved to serve customers 21 and older. The launch came ahead of the original September 7 deadline.
June 2024
24
Jun
Curaleaf Launches Hemp-Derived THC Product Line Nationwide
Curaleaf launched The Hemp Co., a direct-to-consumer hemp-derived THC product line available in 25 states. The move signaled a major pivot by licensed marijuana operators into the unregulated hemp-derived THC market.
17
Jun
Maryland Governor Moore Pardons Over 175,000 Marijuana Convictions
Governor Wes Moore issued a mass pardon covering more than 175,000 low-level marijuana convictions, called the largest such action in U.S. history. Moore called on lawmakers to pass companion legislation enabling full expungement.
1
Jun
Fourth California Cannabis Testing Lab Loses License in Crackdown
California regulators stripped a fourth testing lab's license since December 2023, with Verity Analytics alleged to have inflated THC potency by as much as 32%. The crackdown highlighted systemic issues where labs inflated results to attract business.
May 2024
21
May
DEA Publishes Rescheduling Proposal, Opens 60-Day Public Comment Period
The DEA published its proposed rescheduling rule in the Federal Register, triggering a 60-day public comment period. The agency received more than 40,000 public comments on the proposal.
7
May
New York Launches Massive Crackdown on Unlicensed Cannabis Shops
New York launched a statewide crackdown shuttering nearly 1,350 unlicensed shops and seizing an estimated $63 million in illegal products. New budget legislation enabled immediate padlocking of shops selling illicit cannabis.
April 2024
30
Apr
DEA Agrees to Reschedule Marijuana From Schedule I to Schedule III
The DEA formally circulated a proposal to reclassify marijuana from Schedule I to Schedule III. The move would recognize its medical value, allow cannabis businesses to claim federal tax deductions, and remove certain research barriers.
15
Apr
Cannabis MSOs' Collective 280E Tax Liability Grows to $1.6 Billion
Five major cannabis multistate operators accumulated a combined $1.6 billion in potential 280E tax exposure. The IRS fought back against the strategy, with tax attorneys warning that past taxes paid under 280E are unlikely to be refunded.
December 2023
31
Dec
U.S. Cannabis Sales Projected to Reach $33.6 Billion in 2023
Combined U.S. medical and recreational cannabis sales were projected to hit $33.6 billion for 2023. Growth was driven by new adult-use markets in Missouri, Maryland, and Connecticut, while mature markets saw flat or declining revenues.
15
Dec
Cannabis Industry M&A Volume Hits $1.75 Billion With Smaller Deals
Cannabis mergers and acquisitions totaled $1.75 billion in 2023, with equity and debt capital flows increasing 50% year-over-year. The average deal size of $20.4 million reflected a pivot toward smaller, strategic transactions.
August 2023
29
Aug
HHS Recommends Rescheduling Marijuana to Schedule III
The U.S. Department of Health and Human Services formally recommended that the DEA move marijuana from Schedule I to Schedule III, citing accepted medical use and lower abuse potential. Over 30,000 healthcare practitioners across 43 jurisdictions authorize cannabis for more than 6 million registered patients.
14
Aug
Oklahoma Illicit Cannabis Operations Fuel Interstate Black Market
Investigations revealed Oklahoma's cheap land and low licensing fees attracted criminal organizations using legal-looking grow operations to funnel marijuana into other states' black markets. State authorities ramped up enforcement.
July 2023
31
Jul
Cresco Labs and Columbia Care Terminate $2 Billion Merger
The largest proposed cannabis merger in U.S. history collapsed when Cresco Labs and Columbia Care mutually terminated their $2 billion deal. The companies could not divest enough assets by the regulatory deadline.
26
Jul
Mastercard Orders Banks to Block Cannabis Debit Transactions
Mastercard sent cease-and-desist letters to banks and payment processors, demanding they stop allowing marijuana purchases through its debit card network. The move forced dispensaries to scramble for alternative payment solutions.
15
Jul
California Issues Mandatory Recall Over Deadly Pesticide in Vapes
The California DCC ordered a mandatory recall of vape products after testing detected chlorfenapyr, a Category I pesticide banned for use in cannabis cultivation. The incident highlighted ongoing concerns about product safety.
1
Jul
Maryland Launches Recreational Cannabis Sales
Maryland began adult-use cannabis sales after voters approved legalization in November 2022. The state generated $331.8 million in recreational sales by end of 2023 and collected more than $40 million in tax revenue.
May 2023
30
May
Minnesota Legalizes Recreational Cannabis
Governor Tim Walz signed HF 100, making Minnesota the 23rd state to legalize recreational marijuana. Adults can possess up to two ounces and grow plants at home, with retail sales expected to begin in early 2025.
15
May
Oklahoma Extends Cannabis License Moratorium Amid Massive Oversupply
Governor Stitt signed HB 2095 extending a ban on new medical cannabis business licenses through August 2026. A state study found Oklahoma's regulated supply exceeded demand by 32 times.
3
May
Missouri Hits $1 Billion in Cannabis Sales Within Three Months
Missouri crossed $1 billion in combined cannabis sales just three months after recreational dispensaries opened in February 2023. The state posted $1.4 billion in total revenue during its first year and generated $100 million in tax revenue.
April 2023
23
Apr
Delaware Legalizes Adult-Use Cannabis
Delaware became the 22nd state to legalize recreational marijuana after the governor allowed HB 1 and HB 2 to become law without his signature. Adults 21 and older may possess up to one ounce of flower and 12 grams of concentrates.
11
Apr
Massachusetts Recalls Cannabis Products Over Faulty Microbial Test Kits
The Massachusetts Cannabis Control Commission issued a bulletin after Medicinal Genomics recalled microbial testing kits used across licensed facilities. Products that passed screening using the faulty kits may have entered the retail market.
March 2023
20
Mar
Oregon Cannabis Prices Hit Record Lows as Oversupply Deepens
Oregon's wholesale and retail cannabis prices fell to all-time lows, with flower dropping to roughly $4 per gram as supply doubled demand. Wholesale prices had declined 60% since December 2020, forcing two major industry trade groups to merge.
1
Mar
Hop Latent Viroid Spreads Across Cannabis Industry
Researchers found hop latent viroid had infected 90% of California cannabis grow facilities, causing an estimated $4 billion in annual losses industrywide. The pathogen reduces THC and terpene levels while cutting yields by up to 42%.
January 2023
10
Jan
Connecticut Opens Recreational Cannabis Sales
Nine licensed dispensaries opened doors to recreational customers, generating over $250,000 in the first seven hours. Connecticut became the 20th state to allow retail recreational sales, with purchases initially capped at a quarter-ounce.
1
Jan
California Shifts Cannabis Excise Tax to Point of Retail Sale
California's 15% cannabis excise tax officially moved from distributors to the retail point of sale, following the elimination of the cultivation tax in mid-2022. The restructuring aimed to simplify collections while including a provision to potentially raise the rate to 19% by 2025.